Omya said Wednesday it will showcase its Omyapharm multifunctional excipient platform based on functionalized calcium carbonate, a highly structured mineral At CPhI in Frankfurt.
Omyapharm is suitable for numerous applications, including solid oral dosage forms such as conventional tablets and capsules, microencapsulated products and fast disintegrating formulations. In addition, the company will also present its active pharmaceutical ingredients Omyapure and Omya- Cal, natural calcium carbonates for dietary supplements, antacids and osteoporosis
treatments.
Omyapharm 500-OG is a fine powder consisting of calcium carbonate and tribasic calcium phosphate. It is suitable for wet and dry granulation as well as for hot-melt extrusion. Omyapharm 500-DG OG, meanwhile, is the granulated form of Omyapharm 500-OG and contains a superdisintegrant. Thanks to its special granulation, Omyapharm 500-DG OG offers improved flowability and can be directly compressed into tablets.